🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Progression

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer NCT05534438Phase 28 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Stereotactic body radiotherapy Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease NCT07803055NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: blood sampling VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites📍 Santa Rosa📍 Hartford📍 Washington D.C. VM Oncology, LLC · Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. NCT07062965Phase 3433 sites📍 Anchorage📍 Chandler📍 Gilbert Pfizer · Tests: PF-07248144, Fulvestrant, Everolimus, Exemestane Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression NCT05801471n/a2 sites📍 Milan📍 Roma Centervue SpA Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis NCT07316452n/a1 site📍 Beijing Fu Wai Hospital, Beijing, China Progression Patterns of Choroidal Venous Alterations NCT07236671n/a4 sites📍 Hong Kong📍 Kuala Lumpur📍 Singapore Singapore National Eye Centre Synovial Fluid Bank From Arthritic Patients NCT00512343n/a1 site📍 Sherbrooke Gilles Boire Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcifications NCT07201649NA1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: a blood test and urine sample collection. Impact of Home Intraocular Pressure Telemonitoring on Intraocular Pressure Control and Glaucoma Progression NCT05940623NA1 site📍 Wong Chuk Hang The University of Hong Kong · Tests: Home IOP telemonitoring with smart phone-based intervention, Standard care and smart phone-based intervention CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study NCT06644625n/a1 site📍 Charlotte Wake Forest University Health Sciences · Tests: Blood draw for the laboratory assessment Liposomal Irinotecan and Apatinib in ES-SCLC NCT06749691Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Liposomal Irinotecan and Apatinib Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma NCT03516617Phase 23 sites📍 Scottsdale📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Acalabrutinib, Laboratory Biomarker Analysis, Obinutuzumab, Patient Observation, Quality-of-Life Assessment An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression NCT06079567NA9 sites📍 Leuven📍 Nice📍 Marseille Centre Hospitalier Universitaire de Nice · Tests: Validation of new COMs for FSHD2 patients PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomized Controlled Trial NCT05585411NA8 sites📍 Bucheon-si📍 Changwon📍 Chungju Yonsei University · Tests: Left bundle branch area pacing, Right ventricular pacing Study to Collect High-Resolution ECG Data and Patient Insights on Heart Failure Care NCT06809686n/a2 sites📍 London📍 London Richmond Research Institute Serial Coronary CTA-based Plaque Progression Detection for Management of Coronary Heart Disease NCT06843005NA1 site📍 Nanjing Zhang longjiang,MD · Tests: Coronary Computed Tomography Angiography, Current clinical guidelines Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital Admission NCT07756554NA4 sites📍 Copenhagen📍 Herlev📍 Hillerød Copenhagen University Hospital at Herlev · Tests: Home-based Clinical Assessment and Treatment Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET NCT04954820Phase 228 sites📍 Angers📍 Bordeaux📍 Brest Institut du Cancer de Montpellier - Val d'Aurelle · Tests: Lutathera CHIP/CCUS Natural History Protocol NCT04102423n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Crownlands Observing Progression With Neurons Study NCT07611396n/a1 site📍 Germantown Crownlands I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer NCT01042379Phase 242 sites📍 Birmingham📍 Scottsdale📍 Tucson QuantumLeap Healthcare Collaborative · Tests: Standard Therapy, AMG 386 with or without Trastuzumab, AMG 479 (Ganitumab) plus Metformin, MK-2206 with or without Tras… A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemotherapy, After Treatment Progression in HER-2 Positive Advanced or Metastatic Breast Cancer NCT07455188n/a1 site📍 Zhejiang Zhejiang Cancer Hospital · Tests: Antitumor treatment plan Safety and Efficacy of T10430 Eye Drops in Controlling Paediatric Myopia Progression NCT07522242Phase 210 sites📍 Amman📍 Amman📍 Amman Laboratoires Thea · Tests: T10430 lower dose, T10430 middle dose, T10430 higher dose, Vehicle A Phase II Study of Anlotinib + PD-1 Inhibitor vs. PD-1 Inhibitor Maintenance After First-Line Chemoimmunotherapy in Advanced ESCC (Esophageal Squamous Cell Carcinoma) NCT07863141Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: anlotinib + PD-1 inhibitor, PD-1 inhibitor Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease NCT07267117n/a15 sites📍 Fuzhou📍 Wuhan📍 Changsha Second Affiliated Hospital, Zhejiang University, School of … Progression Suppression and Retinal Regression in VEGF-resistant AMD NCT07005323NA3 sites📍 Nagoya📍 Amagasaki📍 Ube PharmaBio Corporation · Tests: Pars plana vitrectomy The Collagen Factors of Rapid Progression of Keratoconus in Children. NCT06722937n/a1 site📍 Guangzhou Zhongshan Ophthalmic Center, Sun Yat-sen University · Tests: Observation Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression NCT06975332NA2 sites📍 Warsaw📍 Warsaw Medical University of Warsaw · Tests: Local, targeted therapy with alpha emitter [225Ac]Ac-DOTA-SP (TAT) Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC) NCT05931393Phase 21 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Cabozantinib 80 MG
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy